EB-003 — IND submission
2026
In 2026, we are working towards a streamlined IND application for EB-003 in preparation of the initiation of a first-in-human Phase 1 clinical trial.Source filing
ENVB biotech catalysts & pipeline
ENVERIC BIOSCIENCES INC · Data as of 2026-09-08